Articles

The EU should give higher priority to the protection of health and the environment, but when it comes to genetically engineered plants, the current standards of risk assessment are not sufficient to fulfil the legal requirements, writes Christoph Then, executive director at Testbiotech.

(.....)

Currently, more than 70 genetically engineered plants have approval for import into the EU. Most of these plants have more than one trait. One typical example is maize “SmartStax“, developed and marketed by Monsanto (Bayer) and DowDupont (Corteva): it produces six insecticidal Bt toxins and is tolerant to several herbicides.

The gaps in current risk assessment can be exemplified by the fact that this maize was allowed for import into the EU without a single feeding study with the whole food and feed to assess its potential health effects.

There is a long list of gaps in EFSA risk assessment.